Net Cash Provided by (Used in) Operating Activities of NEXIEN BIOPHARMA, INC. from 30 Jun 2014 to 30 Sep 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary
NEXIEN BIOPHARMA, INC. quarterly and annual Net Cash Provided by (Used in) Operating Activities in USD history and change rate from 30 Jun 2014 to 30 Sep 2024.
  • NEXIEN BIOPHARMA, INC. Net Cash Provided by (Used in) Operating Activities for the quarter ending 30 Sep 2024 was $9,230, a 46% increase year-over-year.
  • NEXIEN BIOPHARMA, INC. annual Net Cash Provided by (Used in) Operating Activities for 2024 was $64,364, a 21% increase from 2023.
  • NEXIEN BIOPHARMA, INC. annual Net Cash Provided by (Used in) Operating Activities for 2023 was $81,751, a 8.8% decline from 2022.
  • NEXIEN BIOPHARMA, INC. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $75,143, a 17% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Change (%)

NEXIEN BIOPHARMA, INC. Quarterly Net Cash Provided by (Used in) Operating Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $9,230 +$7,853 +46% 01 Jul 2024 30 Sep 2024 10-Q 18 Nov 2024 2025 Q1
Q3 2023 $17,083 -$1,333 -8.5% 01 Jul 2023 30 Sep 2023 10-Q 18 Nov 2024 2025 Q1
Q3 2022 $15,750 -$1,403 -9.8% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023 2024 Q1
Q3 2021 $14,347 +$1,237 +7.9% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2023 Q1
Q3 2020 $15,584 +$59,951 +79% 01 Jul 2020 30 Sep 2020 10-Q 22 Nov 2021 2022 Q1
Q3 2019 $75,535 +$170,109 +69% 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020 2021 Q1
Q3 2018 $245,644 +$38,260 +13% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2020 Q1
Q3 2017 $283,904 -$278,574 -5227% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018 2019 Q1
Q2 2017 $181,507 27 Mar 2017 30 Jun 2017 10-K 28 Sep 2018 2018 FY
Q3 2016 $5,330 +$94 +1.7% 01 Jul 2016 30 Sep 2016 10-Q 03 Nov 2017 2018 Q1
Q4 2015 $8,774 -$8,774 01 Oct 2015 31 Dec 2015 10-Q 04 Feb 2016 2016 Q2
Q3 2015 $5,424 -$5,424 01 Jul 2015 30 Sep 2015 10-Q 19 Oct 2016 2017 Q1
Q4 2014 $0 01 Oct 2014 31 Dec 2014 10-Q 04 Feb 2016 2016 Q2
Q3 2014 $0 01 Jul 2014 30 Sep 2014 10-Q 14 Oct 2015 2016 Q1

NEXIEN BIOPHARMA, INC. Annual Net Cash Provided by (Used in) Operating Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $64,364 +$17,387 +21% 01 Jul 2023 30 Jun 2024 10-K 22 Oct 2024 2024 FY
2023 $81,751 -$6,608 -8.8% 01 Jul 2022 30 Jun 2023 10-K 22 Oct 2024 2024 FY
2022 $75,143 +$15,602 +17% 01 Jul 2021 30 Jun 2022 10-K 28 Sep 2023 2023 FY
2021 $90,745 +$56,825 +39% 01 Jul 2020 30 Jun 2021 10-K 28 Sep 2022 2022 FY
2020 $147,570 +$495,813 +77% 01 Jul 2019 30 Jun 2020 10-K 12 Oct 2021 2021 FY
2019 $643,383 +$231,959 +26% 01 Jul 2018 30 Jun 2019 10-K 28 Sep 2020 2020 FY
2018 $875,342 -$859,512 -5430% 01 Jul 2017 30 Jun 2018 10-K 30 Sep 2019 2019 FY
2017 $15,830 +$522 +3.2% 01 Jul 2016 30 Jun 2017 10-K 31 Jul 2017 2017 FY
2016 $16,352 +$30,378 +65% 01 Jul 2015 30 Jun 2016 10-K 31 Jul 2017 2017 FY
2015 $46,730 -$46,280 -10284% 01 Jul 2014 30 Jun 2015 10-K 28 Sep 2016 2016 FY
2014 $450 01 Jul 2013 30 Jun 2014 10-K 15 Sep 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.